<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Approximately 10% of adults experience <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> symptoms with a variable oesophageal response </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 60% have no endoscopic abnormality, 30% have <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>, and 10% have <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether the inflammatory cell infiltrate and cytokine profiles of these clinical phenotypes merely vary in severity or are fundamentally different </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Patients with reflux symptoms and a <z:mpath ids='MPATH_458'>normal</z:mpath> oesophagus (n=18), <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> (n=26), and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (n=22 newly diagnosed, n=28 surveillance) were recruited </plain></SENT>
<SENT sid="4" pm="."><plain>Endoscopic and histopathological degrees of <z:mp ids='MP_0001845'>inflammation</z:mp> were scored </plain></SENT>
<SENT sid="5" pm="."><plain>Cytokine expression was determined by competitive reverse transcriptase-polymerase chain reaction and immunohistochemistry </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>, endoscopic and histopathological grades of <z:mp ids='MP_0001845'>inflammation</z:mp> correlated highly </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of proinflammatory interleukin (IL)-1beta, IL-8, and interferon gamma (IFN-gamma) were increased 3-10-fold compared with non-inflamed squamous or Barrett's oesophageal samples </plain></SENT>
<SENT sid="8" pm="."><plain>There was a modest increase in anti-inflammatory IL-10 but no increase in IL-4 </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, 29/50 had no endoscopic evidence of <z:mp ids='MP_0001845'>inflammation</z:mp> and histopathological <z:mp ids='MP_0001845'>inflammation</z:mp> was mild in 17/50 and moderate in 24/50, independent of acid suppressants </plain></SENT>
<SENT sid="10" pm="."><plain>Expression of IL-1beta, IL-8, and IFN-gamma was similar to non-inflamed squamous mucosa </plain></SENT>
<SENT sid="11" pm="."><plain>IL-10 was increased 1.6-fold similar to <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>IL-4 was increased fourfold, with 100-fold increase in IL-4/T cell receptor expression, compared with squamous oesophagus or <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is characterised by a distinct Th-2 predominant cytokine profile compared with the proinflammatory nature of <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The specific oesophageal immune responses may influence disease development and progression </plain></SENT>
</text></document>